What makes ALOXI different?
ALOXI® is an antinausea
medication known as a 5-HT3 receptor antagonist that prevents chemotherapy-induced nausea and vomiting (CINV) after certain
chemotherapies. It works by blocking the antinausea signal to the brain. With some
5-HT3 drugs, patients need to take multiple doses after chemotherapy
to help prevent nausea and vomiting. Not so with ALOXI.
Just one dose of ALOXI may help prevent nausea and vomiting caused by chemotherapy.
A single IV dose before treatment can give you up to 5 days of strength against
certain types of CINV.
This means you may not need to take any additional oral medications for nausea on
the days following chemotherapy.
For certain types of chemotherapy, ALOXI effectively controls:
- Acute CINV: occurs on the same day as chemotherapy treatment, especially
within the first 24 hours
- Delayed CINV: occurs on the days following chemotherapy, usually within 24
to 72 hours
Indication
ALOXI is used in adults to help prevent the nausea and vomiting that can happen
on the day of treatment with certain chemotherapies or occur days later following
chemotherapies moderately likely to cause nausea and vomiting.
Important Safety Information
- Tell your healthcare professional if you are taking other medications or if you
are pregnant or breastfeeding
- The most common side effects of ALOXI® for the prevention of CINV
are headache and constipation
For more information about ALOXI talk to your doctor or see Full Prescribing Information.
ALOXI is available by prescription only.
The health information contained herein is provided for educational purposes only
and is not intended to replace discussions with a healthcare provider. All decisions
regarding patient care must be made with a healthcare provider, considering the
unique characteristics of the patient.
This site is intended for residents of the United States only. The products discussed
herein may have different product labeling in different countries.